Issue link: https://www.e-digitaleditions.com/i/1481708
PharmTech.com Trends in Formulation 2022 eBook Pharmaceutical Technology ® 65 CPHI Exhibitor PROFILES Contact details SCHOTT Pharma AG & Co. KGaA Hattenbergstr. 10, 55122 Mainz, Germany +49 6131 66 0 pharma@schott.com www.schott-pharma.com Hall: 3.0 and Stand: B51 for injectable drugs ranging from prefillable glass and polymer syringes, to cartridges, vials, and ampoules. At CPHI we are looking forward to presenting our innovation products in specialty vials as well as mRNA and ready-to-use containment solutions, including our newly introduced SCHOTT iQ ® Integribag, which is nominated for the CPHI award. SCHOTT Pharma AG & Co. KGaA S CHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world—because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes, to cartridges, vials, and ampoules. Every day, a team of around 4700 people from over 65 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 17 manufacturing sites in Europe, North and South America, and Asia. With over 900 patents and technologies developed in-house, a state-of-the-art R&D center in Switzerland, and around 130 employees in R&D, the company is focused on developing innovations for the future. SCHOTT Pharma AG & Co. KGaA, headquartered in Mainz, Germany, is part of SCHOTT AG that is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030. Currently, SCHOTT Pharma has over 1700 customers including the top 30 leading pharma manufacturers for injectable drugs and generated sales of €650 million in the fiscal year 2021. Major products/services being exhibited Our product portfolio comprises drug containment and delivery solutions We design solutions grounded in science to ensure medicines are safe and easy to use for people around the world. Because human health matters. Contact details TriLink BioTechnologies 10770 Wateridge Cir Ste 200, San Diego, CA 92121 (858) 381-3776 www.trilinkbiotech.com Hall: 9.0 and Stand: D93 Major products/services being exhibited Leading the way in mRNA TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap ® mRNA capping technology. TriLink BioTechnologies T riLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap ® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine, and diagnostic customers.